Michael S. Poirier - Jun 22, 2022 Form 4 Insider Report for Qualigen Therapeutics, Inc. (QLGN)

Role
Chairman and CEO, Director
Signature
/s/ Michael S. Poirier
Stock symbol
QLGN
Transactions as of
Jun 22, 2022
Transactions value $
$17,100
Form type
4
Date filed
6/22/2022, 04:55 PM
Next filing
Aug 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QLGN Common Stock Purchase $17.1K +30K +17.73% $0.57 199K Jun 22, 2022 Direct
holding QLGN Common Stock 11K Jun 22, 2022 By IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24 - Power of Attorney